Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New fatty acid synthase inhibitors patented by GlaxoSmithKline

June 11, 2012

Nektar Therapeutics designs novel polymer-G-CSF conjugates

June 11, 2012

Medivir and Janssen team up to develop new agents for hepatitis

June 11, 2012

Researchers present new mGlu2 receptor modulators

June 11, 2012

Researchers at the CNRS disclose novel inhibitors of tubulin polymerization

June 8, 2012

Janssen and Medivir develop novel agents for hepatitis

June 8, 2012

Novel mineralocorticoid receptor antagonists presented

June 8, 2012

Janssen Pharmaceuticals presents novel mGlu2 receptor modulators

June 8, 2012

Actelion Pharmaceuticals synthesizes novel orexin receptor antagonists

June 8, 2012

Spanish scientists discover new integrin antagonists

June 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...